more_reports

Nabriva Therapeutics Plc

NBRV:NASDAQ

Nabriva is a clinical-stage biopharmaceutical company engaged in the research and development of novel antibiotics to treat serious infections, with a focus on the pleuromutilin class of antibiotics.

streetwise book logo Streetwise Company Fact Sheet

2025/5/31 11:29:27

(NBRV:NASDAQ)